AXA CEO The Impact of Obesity on Health Insurers
· 13.03.2024 · 16:15:38 ··· ··· Wednesday ·· 3 (3)
David Rubenstein AXA CEO Thomas Buberl says we are at the beginning of a revolution in obesity treatment. He shares details on how drugs like Ozempic will positively impact health insurers. He speaks on 'The David Rubenstein Show: Peer-to-Peer Conversations." This interview was recorded January 30 in New York.
· 01.01.1970 · 01:00:00 ···
0**##
· 01.01.1970 · 01:00:00 ···
# · 01.01.1970 · 01:00:00 ···
* · 01.01.1970 · 01:00:00 ···
* · 01.01.1970 · 01:00:00 ···
********
